Detalles de la búsqueda
1.
Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
J Antimicrob Chemother
; 67(6): 1321-4, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22398650
2.
Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.
Antimicrob Agents Chemother
; 55(5): 2344-51, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21343467
3.
In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.
Antimicrob Agents Chemother
; 55(5): 2417-9, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21343445
4.
Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
J Appl Lab Med
; 6(2): 441-450, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152084
5.
Comparative study of the mutant prevention concentrations of moxifloxacin, levofloxacin, and gemifloxacin against pneumococci.
Antimicrob Agents Chemother
; 54(2): 673-7, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20008781
6.
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
Antimicrob Agents Chemother
; 54(1): 230-8, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19884376
7.
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
Antimicrob Agents Chemother
; 53(5): 2176-80, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19237649
8.
In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types.
Antimicrob Agents Chemother
; 53(2): 811-3, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19029326
9.
Comparative antipneumococcal activities of sulopenem and other drugs.
Antimicrob Agents Chemother
; 53(6): 2239-47, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19307366
10.
Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.
Antimicrob Agents Chemother
; 53(7): 3118-21, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19433566
11.
Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.
Antimicrob Agents Chemother
; 53(10): 4217-24, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19620338
12.
Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.
Antimicrob Agents Chemother
; 53(4): 1353-61, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19188385
13.
Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.
Antimicrob Agents Chemother
; 52(12): 4510-3, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18838583
14.
In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactams.
Diagn Microbiol Infect Dis
; 49(1): 31-6, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15135497
15.
Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital.
Diagn Microbiol Infect Dis
; 68(1): 34-9, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20727467
16.
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
Antimicrob Agents Chemother
; 52(1): 77-84, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17938189
17.
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.
Antimicrob Agents Chemother
; 51(2): 770-3, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17116666
18.
Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents.
Antimicrob Agents Chemother
; 51(11): 4191-5, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17875997
19.
Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes.
Antimicrob Agents Chemother
; 50(2): 765-9, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16436741
20.
Activity of LBM415 compared to those of 11 other agents against Haemophilus species.
Antimicrob Agents Chemother
; 50(7): 2323-9, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16801408